Building momentum for malaria vaccine research and development: key considerations

被引：0
|
作者：
Chetan E. Chitnis
David Schellenberg
Johan Vekemans
Edwin J. Asturias
Philip Bejon
Katharine A. Collins
Brendan S. Crabb
Socrates Herrera
Miriam Laufer
N. Regina Rabinovich
Meta Roestenberg
Adelaide Shearley
Halidou Tinto
Marian Wentworth
Kate O’Brien
Pedro Alonso
机构：
[1] Institut Pasteur,Department of Medical Microbiology
[2] World Health Organization,undefined
[3] University of Colorado School of Medicine and Colorado School of Public Health,undefined
[4] KEMRI-Wellcome Trust Research Programme,undefined
[5] Radboud University Medical Center,undefined
[6] Burnet Institute,undefined
[7] Consorcio Para La Investigacion Cientifica,undefined
[8] University of Maryland School of Medicine,undefined
[9] IS Global,undefined
[10] Harvard TH Chan School of Public Health,undefined
[11] Leiden University Medical Center,undefined
[12] John Snow Inc,undefined
[13] Research & Training Institute,undefined
[14] Institut de Recherche en Sciences de La Santé,undefined
[15] Management Sciences for Health,undefined
来源：
Malaria Journal | / 19卷
关键词：
Malaria; Vaccine; Control; Elimination; Research and development;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and discovery to identify and develop highly effective, long-lasting and affordable next generation malaria vaccines.
引用
收藏
相关论文
共 50 条
  • [1] Building momentum for malaria vaccine research and development: key considerations
    Chitnis, Chetan E.
    Schellenberg, David
    Vekemans, Johan
    Asturias, Edwin J.
    Bejon, Philip
    Collins, Katharine A.
    Crabb, Brendan S.
    Herrera, Socrates
    Laufer, Miriam
    Rabinovich, N. Regina
    Roestenberg, Meta
    Shearley, Adelaide
    Tinto, Halidou
    Wentworth, Marian
    O'Brien, Kate
    Alonso, Pedro
    MALARIA JOURNAL, 2020, 19 (01)
  • [2] Key Considerations for Development and Production of Vaccine Products
    Rathore, Anurag S.
    Jadhav, Suresh
    Bhalghat, Mahesh
    Kandawalla, Shiraz
    Ray, Suma
    Patra, Ashok Kumar
    BIOPHARM INTERNATIONAL, 2012, : S28 - S34
  • [3] Peptide based malaria vaccine development: personal considerations
    Corradin, Giampietro
    MICROBES AND INFECTION, 2007, 9 (06) : 767 - 771
  • [4] Status of vaccine research and development of vaccines for malaria
    Birkett, Ashley J.
    VACCINE, 2016, 34 (26) : 2915 - 2920
  • [5] A review of human vaccine research and development: Malaria
    Girard, Marc P.
    Reed, Zarifah H.
    Friede, Martin
    Kieny, Marie Paule
    VACCINE, 2007, 25 (09) : 1567 - 1580
  • [6] Building a better malaria vaccine
    Anthony King
    Nature, 2019, 575 (7784) : S51 - S54
  • [7] VACCINE DEVELOPMENT RELATED MALARIA RESEARCH - AN INTERIM REVIEW
    MEUWISSEN, JHET
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1987, 39 (03): : 316 - 317
  • [8] Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development
    Galinski, MR
    Barnwell, JW
    PARASITOLOGY TODAY, 1996, 12 (01): : 20 - 29
  • [9] MALARIA VACCINE RESEARCH
    BALLOU, WR
    DIGGS, CL
    LANDRY, S
    HALL, BF
    SCIENCE, 1994, 266 (5192) : 1792 - 1792
  • [10] GENETIC CONSIDERATIONS IN THE DESIGN OF A MALARIA VACCINE
    RZEPCZYK, CM
    PAPUA NEW GUINEA MEDICAL JOURNAL, 1989, 32 (04) : 251 - 258
12345